Division of Epidemiology and Biostatistics, School of Public Health, University of California, Berkeley, Berkeley, CA, 94720, USA
Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA, USA.
BMJ. 2020 May 22;369:m1923. doi: 10.1136/bmj.m1923.
To understand the epidemiology and burden of severe coronavirus disease 2019 (covid-19) during the first epidemic wave on the west coast of the United States.
Prospective cohort study.
Kaiser Permanente integrated healthcare delivery systems serving populations in northern California, southern California, and Washington state.
1840 people with a first acute hospital admission for confirmed covid-19 by 22 April 2020, among 9 596 321 healthcare plan enrollees. Analyses of hospital length of stay and clinical outcomes included 1328 people admitted by 9 April 2020 (534 in northern California, 711 in southern California, and 83 in Washington).
Cumulative incidence of first acute hospital admission for confirmed covid-19, and subsequent probabilities of admission to an intensive care unit (ICU) and mortality, as well as duration of hospital stay and ICU stay. The effective reproduction number ( ) describing transmission dynamics was estimated for each region.
As of 22 April 2020, cumulative incidences of a first acute hospital admission for covid-19 were 15.6 per 100 000 cohort members in northern California, 23.3 per 100 000 in southern California, and 14.7 per 100 000 in Washington. Accounting for censoring of incomplete hospital stays among those admitted by 9 April 2020, the estimated median duration of stay among survivors was 9.3 days (with 95% staying 0.8 to 32.9 days) and among non-survivors was 12.7 days (1.6 to 37.7 days). The censoring adjusted probability of ICU admission for male patients was 48.5% (95% confidence interval 41.8% to 56.3%) and for female patients was 32.0% (26.6% to 38.4%). For patients requiring critical care, the median duration of ICU stay was 10.6 days (with 95% staying 1.3 to 30.8 days). The censoring adjusted case fatality ratio was 23.5% (95% confidence interval 19.6% to 28.2%) among male inpatients and 14.9% (11.8% to 18.6%) among female inpatients; mortality risk increased with age for both male and female patients. Reductions in were identified over the study period within each region.
Among residents of California and Washington state enrolled in Kaiser Permanente healthcare plans who were admitted to hospital with covid-19, the probabilities of ICU admission, of long hospital stay, and of mortality were identified to be high. Incidence rates of new hospital admissions have stabilized or declined in conjunction with implementation of social distancing interventions.
了解美国西海岸首次冠状病毒病 2019(covid-19)流行期间严重 covid-19 的流行病学和负担。
前瞻性队列研究。
在加利福尼亚州北部、加利福尼亚州南部和华盛顿州为人群提供综合医疗服务的 Kaiser Permanente 综合医疗系统。
2020 年 4 月 22 日前因确诊的 covid-19 首次急性住院的 1840 人,其中有 9596321 名医疗计划参保人。对住院时间和临床结果的分析包括 2020 年 4 月 9 日前入院的 1328 人(加利福尼亚州北部 534 人,加利福尼亚州南部 711 人,华盛顿州 83 人)。
确诊的 covid-19 首次急性住院的累积发病率,以及随后 ICU 住院和死亡率的概率,以及住院和 ICU 住院的持续时间。为每个地区估计了描述传播动力学的有效繁殖数()。
截至 2020 年 4 月 22 日,加利福尼亚州北部、加利福尼亚州南部和华盛顿州的首次急性医院入院累积发病率分别为每 100000 名队列成员 15.6、23.3 和 14.7。考虑到 2020 年 4 月 9 日前入院患者的不完全住院时间的删失,幸存者的估计中位住院时间为 9.3 天(95%置信区间为 0.8 至 32.9 天),非幸存者为 12.7 天(1.6 至 37.7 天)。男性患者 ICU 入院的删失调整概率为 48.5%(95%置信区间为 41.8%至 56.3%),女性患者为 32.0%(26.6%至 38.4%)。对于需要重症监护的患者,ICU 住院的中位时间为 10.6 天(95%置信区间为 1.3 至 30.8 天)。男性住院患者的病死率调整比值为 23.5%(95%置信区间为 19.6%至 28.2%),女性住院患者为 14.9%(11.8%至 18.6%);男性和女性患者的死亡率均随年龄增长而增加。在每个地区,研究期间均发现的减少。
在加利福尼亚州和华盛顿州参加 Kaiser Permanente 医疗保健计划并因 covid-19 住院的居民中,ICU 入院、住院时间长和死亡率的概率均被确定为高。新住院发病率的下降与社会隔离干预措施的实施同时发生或下降。